Research and Development

Merck has become the first company to bring a new class of cancer drug to the US market after the …

Johnson & Johnson has announced it is to fast-track the development of a new vaccine programme to fight the deadly …

AbbVie has partnered with US company Infinity Pharmaceuticals to develop and commercialise the latter firm’s blood cancer treatment duvelisib (IPI-145). …

The Healthcare Communications Association (HCA) has a new chief executive in Anneliese Cameron who replaces Julia Cook next year in …

Google’s healthcare company Calico has signed its first pharma pact with US firm AbbVie in a deal that could be …

Healthcare outsourced development firm ICON has hired Dr Ira Spector to be the executive vice president of its analytics and …

Digital science portfolio firm BioData that produces web-based research and lab management service Labguru, has appointed Louis Culot as its …

NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …

A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …

The European Medicines Agency has confirmed two new appointments to join its management team.  Marie-Agnes Heine (pictured) has joined to …

The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …

German biopharma firm BioNTech has announced that Sierk Pötting will be joining its management team as its chief financial officer, …

AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …

Set to be the biggest country for pharma growth in the 21st century, with rising levels of chronic disease, an …

Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …